ResMed (RMD) Reports In-Line Q4 EPS, Revenues Slightly Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2018
August 2, 2018 4:05 PM EDTRevenue increased 12% to $623.6 million; up 10% on a constant currency basis Net income increased by 8%; non-GAAP net income up 24% GAAP diluted earnings per share of $0.76; non-GAAP diluted earnings per share of $0.95 Operating cash flow of $129.4 million in the fourth quarter Quarterly dividend increased by 6% to $0.37 per share
SAN DIEGO--(BUSINESS WIRE)-- ResMed Inc. (NYSE: RMD) (ASX: RMD) today announced results for... More
